NZ505073A - Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases - Google Patents
Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseasesInfo
- Publication number
- NZ505073A NZ505073A NZ505073A NZ50507398A NZ505073A NZ 505073 A NZ505073 A NZ 505073A NZ 505073 A NZ505073 A NZ 505073A NZ 50507398 A NZ50507398 A NZ 50507398A NZ 505073 A NZ505073 A NZ 505073A
- Authority
- NZ
- New Zealand
- Prior art keywords
- micelles
- useful
- surfactant
- inflammatory
- pharmaceutical compositions
- Prior art date
Links
- 239000000693 micelle Substances 0.000 title abstract 3
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 230000000172 allergic effect Effects 0.000 title abstract 2
- 239000003862 glucocorticoid Substances 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title 1
- 208000028774 intestinal disease Diseases 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 title 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008180 pharmaceutical surfactant Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704833A SE9704833D0 (sv) | 1997-12-22 | 1997-12-22 | New formulation |
| PCT/SE1998/002426 WO1999032089A1 (en) | 1997-12-22 | 1998-12-22 | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ505073A true NZ505073A (en) | 2002-09-27 |
Family
ID=20409536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ505073A NZ505073A (en) | 1997-12-22 | 1998-12-22 | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1043973A1 (xx) |
| JP (1) | JP2001526210A (xx) |
| KR (1) | KR20010024789A (xx) |
| CN (1) | CN1283106A (xx) |
| AR (1) | AR017220A1 (xx) |
| AU (1) | AU1993599A (xx) |
| BR (1) | BR9813811A (xx) |
| CA (1) | CA2315782A1 (xx) |
| EE (1) | EE200000388A (xx) |
| HU (1) | HUP0102365A3 (xx) |
| ID (1) | ID26945A (xx) |
| IL (1) | IL136880A0 (xx) |
| NO (1) | NO20003220L (xx) |
| NZ (1) | NZ505073A (xx) |
| PL (1) | PL341361A1 (xx) |
| SE (1) | SE9704833D0 (xx) |
| SK (1) | SK9532000A3 (xx) |
| TR (1) | TR200001977T2 (xx) |
| WO (1) | WO1999032089A1 (xx) |
| ZA (1) | ZA9811461B (xx) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9902674D0 (sv) * | 1999-07-12 | 1999-07-12 | Astra Ab | New composition |
| SE0000332D0 (sv) * | 2000-01-31 | 2000-01-31 | Astrazeneca Ab | New use |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| KR100889426B1 (ko) | 2000-08-05 | 2009-03-23 | 글락소 그룹 리미티드 | 항염증제로서의 6.알파.,9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르 |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| SE0100901D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | New composition |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| AU2002253342B2 (en) | 2001-04-30 | 2007-01-04 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| EP1661556A4 (en) * | 2003-08-20 | 2010-05-19 | Ajinomoto Kk | MEDICAL PREPARATION WITH IMPROVED RESOLUTION CHARACTERISTICS |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| CN100579510C (zh) * | 2006-04-13 | 2010-01-13 | 新疆维吾尔自治区包虫病临床研究所 | 新型前体胶束制剂及其生产方法 |
| WO2009064458A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090143343A1 (en) | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| MX2011002688A (es) * | 2008-09-12 | 2011-04-12 | Critical Pharmaceuticals Ltd | Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel. |
| CN101982168B (zh) * | 2010-11-02 | 2012-05-23 | 山东大学 | 一种槲皮素纳米胶束制剂及其制备方法 |
| CN102793678B (zh) * | 2011-05-26 | 2017-06-30 | 邓世明 | 一种不含吐温的多烯紫杉醇注射剂的制备方法 |
| DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
| JP5456802B2 (ja) * | 2012-01-23 | 2014-04-02 | 株式会社Ｃａｃ | 細胞遊走促進剤及び創傷治療用の経皮吸収剤 |
| US10596115B2 (en) * | 2013-07-17 | 2020-03-24 | Council Of Scientific & Industrial Research | Pharmaceutical composition for the treatment of diminution of bone tissue |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| MX2018011705A (es) | 2016-04-01 | 2019-06-10 | Therapeuticsmd Inc | Composicion farmaceutica de hormona esteroide. |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| KR102086316B1 (ko) * | 2019-09-09 | 2020-03-09 | 한국콜마주식회사 | 경피흡수성이 우수한 화장료 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| SA95160463B1 (ar) * | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
-
1997
- 1997-12-22 SE SE9704833A patent/SE9704833D0/xx unknown
-
1998
- 1998-12-14 ZA ZA9811461A patent/ZA9811461B/xx unknown
- 1998-12-17 AR ARP980106453A patent/AR017220A1/es not_active Application Discontinuation
- 1998-12-22 AU AU19935/99A patent/AU1993599A/en not_active Abandoned
- 1998-12-22 KR KR1020007006879A patent/KR20010024789A/ko not_active Withdrawn
- 1998-12-22 TR TR2000/01977T patent/TR200001977T2/xx unknown
- 1998-12-22 IL IL13688098A patent/IL136880A0/xx unknown
- 1998-12-22 BR BR9813811-1A patent/BR9813811A/pt not_active IP Right Cessation
- 1998-12-22 ID IDW20001131A patent/ID26945A/id unknown
- 1998-12-22 WO PCT/SE1998/002426 patent/WO1999032089A1/en not_active Ceased
- 1998-12-22 SK SK953-2000A patent/SK9532000A3/sk unknown
- 1998-12-22 CN CN98812507A patent/CN1283106A/zh active Pending
- 1998-12-22 EE EEP200000388A patent/EE200000388A/xx unknown
- 1998-12-22 HU HU0102365A patent/HUP0102365A3/hu unknown
- 1998-12-22 NZ NZ505073A patent/NZ505073A/xx unknown
- 1998-12-22 CA CA002315782A patent/CA2315782A1/en not_active Abandoned
- 1998-12-22 PL PL98341361A patent/PL341361A1/xx unknown
- 1998-12-22 JP JP2000525082A patent/JP2001526210A/ja active Pending
- 1998-12-22 EP EP98964662A patent/EP1043973A1/en not_active Withdrawn
-
2000
- 2000-06-21 NO NO20003220A patent/NO20003220L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL341361A1 (en) | 2001-04-09 |
| TR200001977T2 (tr) | 2000-12-21 |
| HUP0102365A2 (hu) | 2001-11-28 |
| EE200000388A (et) | 2002-02-15 |
| AR017220A1 (es) | 2001-08-22 |
| WO1999032089A1 (en) | 1999-07-01 |
| ZA9811461B (en) | 1999-06-22 |
| HUP0102365A3 (en) | 2002-01-28 |
| SK9532000A3 (en) | 2000-11-07 |
| SE9704833D0 (sv) | 1997-12-22 |
| EP1043973A1 (en) | 2000-10-18 |
| NO20003220L (no) | 2000-08-22 |
| ID26945A (id) | 2001-02-22 |
| BR9813811A (pt) | 2000-10-03 |
| CN1283106A (zh) | 2001-02-07 |
| IL136880A0 (en) | 2001-06-14 |
| KR20010024789A (ko) | 2001-03-26 |
| CA2315782A1 (en) | 1999-07-01 |
| AU1993599A (en) | 1999-07-12 |
| NO20003220D0 (no) | 2000-06-21 |
| JP2001526210A (ja) | 2001-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ505073A (en) | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases | |
| GC0000107A (en) | Water - soluble pharmaceutical compositions in an ionic complex an the use thereof. | |
| IT1271462B (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
| WO1999049883A3 (en) | Oxidized thymosin beta 4 | |
| TR200102110T2 (tr) | Astım için formoterol ve flütikazon propiyonat kombinasyonları. | |
| EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
| BR0112962B1 (pt) | Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos | |
| CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
| DK1095932T3 (da) | Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme | |
| ZA200007299B (en) | Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol. | |
| NZ298677A (en) | Hydroxamic acid derivatives, preparation and pharmaceutical compositions thereof | |
| DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
| HUP0103165A3 (en) | Thiazoline acid derivatives, pharmaceutical compositions containig the same and their use | |
| DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
| PT1071433E (pt) | 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados | |
| CA2325360A1 (en) | Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases | |
| AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| NO990335D0 (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
| EP0670166A3 (en) | Pharmaceutical compositions for oral administration. | |
| DE59708495D1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
| IL153540A0 (en) | THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | |
| DZ1926A1 (fr) | Formulations pharmaceutiques. | |
| MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
| AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |